Anti-LCAT 抗体 [EPR1383(2)]
Anti-LCAT antibody [EPR1383(2)]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal LCAT antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 5 publications.
別名を表示する
Phosphatidylcholine-sterol acyltransferase, 1-alkyl-2-acetylglycerophosphocholine esterase, Lecithin-cholesterol acyltransferase, Phospholipid-cholesterol acyltransferase, Platelet-activating factor acetylhydrolase, PAF acetylhydrolase, LCAT
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCAT antibody [EPR1383(2)] (AB109417)
ab109417 at 1/250 dilution staining LCAT in paraffin-embedded Human liver tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-LCAT antibody [EPR1383(2)] (AB109417)
All lanes:
Western blot - Anti-LCAT antibody [EPR1383(2)] (ab109417) at 1/1000 dilution
Lane 1:
Human serum lysate at 10 µg
Lane 2:
Human plasma lysate at 10 µg
Predicted band size: 50 kDa
false
- WB
Lab
Western blot - Anti-LCAT antibody [EPR1383(2)] (AB109417)
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
Exposure time : Lane 1-3, 7-9 : 180 seconds; Lane 4-6 : 140 seconds
Low expression : HEK 293 (PMID : 7721870).
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
ab109417 is more sensitive than ab51060 in WB testing.
Lanes 1 - 6:
Western blot - Anti-LCAT antibody [EPR1384Y] (<a href='/products/primary-antibodies/lcat-antibody-epr1384y-ab51060'>ab51060</a>) at 1/1000 dilution
Lanes 7 - 9:
Western blot - Anti-LCAT antibody [EPR1383(2)] (ab109417) at 1/1000 dilution
Lanes 1, 4 and 7:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lanes 2, 5 and 8:
COS-1 (Cercopithecus aethiops kidney epithelial) whole cell lysate at 20 µg
Lanes 3, 6 and 9:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 62 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-LCAT antibody [EPR1383(2)] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This enzyme functions centrally in the maturation of high-density lipoprotein particles. LCAT interacts with and acts upon HDL converting nascent HDL into mature HDL by catalyzing the esterification of cholesterol. This process results in the sequestration of cholesterol within the core of HDL particles essential for reverse cholesterol transport to the liver. Moreover LCAT does not operate as part of a larger complex but is an active enzyme on its own within various lipid transport processes.
Pathways
LCAT's action significantly influences the lipid metabolism and reverse cholesterol transport pathways. In the lipid metabolism pathway it works closely with apolipoproteins such as apoA-I which serves as an activator. ApoA-I stabilizes the enzymatic action of LCAT promoting cholesterol homeostasis whereas LCAT ensures the efficient transfer of cholesterol to the liver within the reverse cholesterol transport pathway contributing to the maintenance of lipid balance.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (5)
Recent publications for all applications. Explore the full list and refine your search
Experimental and therapeutic medicine 30:208 PubMed40927640
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 12:1612390 PubMed40927188
2025
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastrointestinal oncology 16:3651-3671 PubMed39171187
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 25: PubMed33266249
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 9: PubMed31779197
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com